Work

Abstract CT086: A phase 1/2, first-in-human study of an ADC targeting CDH17 (DB-1324) in participants with advanced/metastatic gastrointestinal tumor

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct086

Authors: Lin Shen, Jifang Gong, Jermaine Coward, Rajiv Shinde, Joe Wei, Yanhong Deng, Yanqiao Zhang, Ming Lu, Meili Sun, Sreenivasa Chandana, Davendra Sohal, Ting Zhang, Hua Mu, Yuran Liang, Haiqing Hua, Xiaodong Sun, Yang Qiu, Jiajia Chen, Zhongyuan Zhu

Institutions: Peking University Cancer Hospital, Icon (Australia), Linear Clinical Research, Sixth Affiliated Hospital of Sun Yat-sen University, Harbin Medical University, Jinan Central Hospital, University of Cincinnati Medical Center, Duality Biotherapeutics, Inc. (China)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154704633

Cites:

Cited by:

Related to: